I-Tirzepatide Hloyini Ukuhlanzeka Okuphezulu okuphezulu 99% Peptide Powder Tr 10mg 15mg 20mg 20mg 20mg 30

I-TirzePatide i-insulinotropic ethembekile ye-insulinotropic-ancike e-anulide / glucagon-efana ne-peptide 1 (glp-1) i-agonist e-United States evunyelwe ekuphathweni kwesisindo esingamahlalakhona, okusebenzayo kwezinye izimo, kufaka phakathi ukwehluleka kwenhliziyo ngengxenye ye-ejection egcinwe futhi ukukhuluphala kanye ne-non-cirrhhotic angewona-akayo steatohepatitis. Isigaba 3 sedlula uhlelo lokuqulwa kwecala lwe-1-5 lwenzelwe ukuhlola ukusebenza kahle kwe-tirzepatide okungu-5, 10, 10 no-15 mg), njengokwelashwa okubanzi noma okuhlanganisiwe kwesimo sabantu esinesifo sikashukela sohlobo 2. Ukusetshenziswa kwe-TirzePtide ezifundweni zemitholampilo kuhlotshaniswa nokuncishiswa okumakiwe kwe-hemoglobin (-1.87 kuya ku -2.59% ama-triglycerides. I-TirtzePatide ibibekezeleleke kahle, ngokuba nengozi ephansi ye-hypoglycaemia lapho isetshenziswa ngaphandle kwe-insulin noma i-insulin onokhokho futhi ikhombise iphrofayili yezokuphepha efanayo nekilasi le-purp-1 receptor agonist. Ngokuvumelana nalokhu, ubufakazi obuvela kulezi zivivinyo zomtholampilo bubonisa ukuthi i-tiirzepatide inikeza ithuba elisha lokunciphisa ngempumelelo kwe-hemoglobin esebenza ngempumelelo kanye nesisindo somzimba kubantu abadala abanesifo sikashukela sohlobo 2.